AorTech International PLC Result of AGM (5270J)
August 19 2019 - 9:53AM
UK Regulatory
TIDMAOR
RNS Number : 5270J
AorTech International PLC
19 August 2019
19 August 2019
AorTech International plc
("AorTech")
Result of AGM
AorTech International plc (AIM: AOR), the biomaterials IP and
medical device development company, announces that all resolutions
put to shareholders at its Annual General Meeting held earlier
today, were duly passed.
For further information contact:
AorTech International plc Tel: +44 (0)7730 718296
Bill Brown, Chairman
Shore Capital Tel: +44 (0)20 7408 4080
Tom Griffiths/David Coaten
About AorTech:
AorTech has developed biostable, implantable polymers, including
Elast-Eon(TM) and ECSil(TM) the world's leading long-term
implantable co-polymers, now manufactured on its behalf by
Biomerics LLC in Utah, USA. Elast-Eon(TM) and ECSil(TM)'s
biostability is comparable to silicone while exhibiting excellent
mechanical, blood contacting and flex-fatigue properties. These
polymers can be processed using conventional thermoplastic
extrusion and moulding techniques. With over 6 million implants and
over 10 years of successful clinical use AorTech polymers are
proven in long term life enabling applications.
In addition to continuing to exploit AorTech's Intellectual
Property related to the world class biomaterial - Elast-Eon(TM),
AorTech is now incorporating this material into a number of medical
devices of our own design. Elast-Eon(TM) has first class long term
blood contacting properties and as a result, all of the initial
products being developed are for the cardio vascular field. Each
device is being designed to have improved clinical outcomes over
current device technology,eliminating the use of animal sourced
material whilst allowing procedures to remain the same, therefore
avoiding the need of having to retrain surgeons in new ways of
operating.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGPLMJTMBABBBL
(END) Dow Jones Newswires
August 19, 2019 09:53 ET (13:53 GMT)
Rua Life Sciences (LSE:RUA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Rua Life Sciences (LSE:RUA)
Historical Stock Chart
From Apr 2023 to Apr 2024